Market Value of Evelo Biosciences Collapses as Delisting Looms Evelo Biosciences’ market capitalization has plummeted to just $10,000, reflecting a 99% loss in share value over the past year. Once valued far higher, the company’s collapse highlights the risks of biotech investing, especially as analyst sentiment has shifted from optimism to caution in recent months.45